StockData
AstraZeneca PLC logo

AstraZeneca PLC (AZN) operating KPIs

AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)

Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%

AstraZeneca taxation ($M) ($M)

Consolidated Income Statement (Postgres DB + Form 6-K Q1–Q4)

QuarterlyAnnual
Latest, Q2 2026
291
Period ended Jun 30, 2026
Change on a year earlier
-57.1%
679 in Q2 2025
History
27 quarters
Since Q2 2017
Sources
26
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedTaxation ($M) ($M)Year on yearSource
Q2 2026Jun 30, 2026291-57.1%Form 6-K (filed 2026-07-27) ↗
Q1 2026Mar 31, 2026-833+73.2%Form 6-K FY2026Q1 Earnings Release ↗
Q4 2025Dec 31, 2025-300+80.7%Form 6-K FY2025Q4 Earnings Release ↗
Q3 2025Sep 30, 2025-709+79.5%Form 6-K FY2025Q3 Earnings Release ↗
Q2 2025Jun 30, 2025679+44.8%Form 6-K (filed 2025-07-29) ↗
Q1 2025Mar 31, 2025-481-22.4%Form 6-K FY2025Q1 Earnings Release ↗
Q4 2024Dec 31, 2024-166+167.7%Form 6-K FY2024Q4 Earnings Release ↗
Q3 2024Sep 30, 2024-395+44.2%Form 6-K FY2024Q3 Earnings Release ↗
Q2 2024Jun 30, 2024469+75.0%Form 6-K (filed 2024-07-25) ↗
Q1 2024Mar 31, 2024-620+35.4%Form 6-K FY2024Q1 Earnings Release ↗
Q4 2023Dec 31, 2023-62-50.0%Form 6-K FY2023Q4 Earnings Release ↗
Q3 2023Sep 30, 2023-274-61.9%Form 6-K FY2023Q3 Earnings Release ↗
Q2 2023Jun 30, 2023268-337.2%Form 6-K (filed 2023-07-28) ↗
Q1 2023Mar 31, 2023-458+177.6%Form 6-K FY2023Q1 Earnings Release ↗
Q4 2022Dec 31, 2022-124-57.2%Form 6-K FY2022Q4 Earnings Release ↗
Q3 2022Sep 30, 2022-720+105.7%Form 6-K FY2022Q3 Earnings Release ↗

Cite this data

StockData. (2026). AstraZeneca Taxation ($M) ($M), quarterly Q2 2017–Q2 2026 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/fin_tax

See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.